Tomer Greener

456 total citations
14 papers, 349 citations indexed

About

Tomer Greener is a scholar working on Genetics, Epidemiology and Gastroenterology. According to data from OpenAlex, Tomer Greener has authored 14 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Epidemiology and 6 papers in Gastroenterology. Recurrent topics in Tomer Greener's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (9 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Tomer Greener is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (9 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Tomer Greener collaborates with scholars based in Israel, Canada and United States. Tomer Greener's co-authors include Uri Kopylov, Shomron Ben‐Horin, Marianne Michal Amitai, Eyal Klang, Noa Rozendorn, Rami Eliakim, Nina Levhar, Sandra Neuman, Adi Lahat and Doron Yablecovitch and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Diseases of the Colon & Rectum.

In The Last Decade

Tomer Greener

13 papers receiving 347 citations

Peers

Tomer Greener
Tomer Greener
Citations per year, relative to Tomer Greener Tomer Greener (= 1×) peers Satoshi Motoya

Countries citing papers authored by Tomer Greener

Since Specialization
Citations

This map shows the geographic impact of Tomer Greener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomer Greener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomer Greener more than expected).

Fields of papers citing papers by Tomer Greener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomer Greener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomer Greener. The network helps show where Tomer Greener may publish in the future.

Co-authorship network of co-authors of Tomer Greener

This figure shows the co-authorship network connecting the top 25 collaborators of Tomer Greener. A scholar is included among the top collaborators of Tomer Greener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomer Greener. Tomer Greener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Greener, Tomer, Karen Boland, Raquel Milgrom, et al.. (2021). Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients. European Journal of Gastroenterology & Hepatology. 33(10). 1274–1279. 3 indexed citations
3.
Lee, Sun-Ho, Eun Hye Oh, Sung Wook Hwang, et al.. (2020). Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment. Inflammatory Bowel Diseases. 27(9). 1452–1461. 18 indexed citations
4.
Sbeit, Wisam, Tomer Greener, Amir Mari, et al.. (2020). Pancreatobiliary manifestations of nonalcoholic fatty liver disease: a retrospective case-control multicenter study. European Journal of Gastroenterology & Hepatology. 33(5). 722–726. 4 indexed citations
5.
Boland, Karen, Tomer Greener, Boyko Kabakchiev, et al.. (2019). Identification of Target Golimumab Levels in Maintenance Therapy of Crohn’s Disease and Ulcerative Colitis Associated With Mucosal Healing. Inflammatory Bowel Diseases. 26(5). 766–773. 8 indexed citations
6.
Amitai, Marianne Michal, Eyal Klang, Noa Rozendorn, et al.. (2018). Diffusion-weighted magnetic resonance enterography for prediction of response to tumor necrosis factor inhibitors in stricturing Crohn’s disease. Abdominal Radiology. 43(12). 3207–3212. 14 indexed citations
7.
Greener, Tomer, Boyko Kabakchiev, A. Hillary Steinhart, & Mark S. Silverberg. (2018). Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(8). 1808–1814. 36 indexed citations
8.
Greener, Tomer, Karen Boland, A. Hillary Steinhart, & Mark S. Silverberg. (2017). The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease. Journal of Crohn s and Colitis. 12(4). 458–464. 16 indexed citations
9.
Greener, Tomer, Boyko Kabakchiev, & Mark S. Silverberg. (2017). High Infliximab Levels are not Associated with a Higher Risk of Infection in IBD Patients. Gastroenterology. 152(5). S108–S108. 2 indexed citations
10.
Greener, Tomer, Eyal Klang, Doron Yablecovitch, et al.. (2016). The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn’s Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study. Journal of Crohn s and Colitis. 10(5). 525–531. 59 indexed citations
11.
Kopylov, Uri, Eyal Klang, Doron Yablecovitch, et al.. (2016). Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease. Therapeutic Advances in Gastroenterology. 9(5). 655–663. 39 indexed citations
12.
Greener, Tomer, Ron Shapiro, Eyal Klang, et al.. (2015). Clinical Outcomes of Surgery Versus Endoscopic Balloon Dilation for Stricturing Crohn’s Disease. Diseases of the Colon & Rectum. 58(12). 1151–1157. 34 indexed citations
13.
Kopylov, Uri, Doron Yablecovitch, Adi Lahat, et al.. (2015). Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn’s Disease Using Biomarkers, Capsule Endoscopy, and Imaging. The American Journal of Gastroenterology. 110(9). 1316–1323. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026